|

CKD-703 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Chong Kun Dang Pharmaceutical1

Indications

  • Advanced Solid Tumors1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Ohio City, Ohio1 trial

A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer

Gabrail Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.